APP and Alzheimer disease: The treatment of Alzheimer's disease transgenic mice expressing mutant human amyloid precursor protein (APP) and presenilin-1 (PS1) with the DQ detoxification cocktail selectively eliminated senescent cells and reduced neuroinflammation while improving cognitive deficits [254].